Takeda Pharmaceutical Company Limited Comprehensive Income Attributable To Owners Of Parent
Takeda Pharmaceutical Company Limited (TAK) reported Comprehensive Income Attributable To Owners Of Parent of -JPY 57.85 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent · last filed 2025-06-25
| Period end | Comprehensive Income Attributable To Owners Of Parent 12 month | Comprehensive Income Attributable To Owners Of Parent 12 month as first filed |
|---|---|---|
| 2025-03-31 | -57.85B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 1.14T JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 911.53B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 824.26B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 697.20B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | -199.57B JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 121.86B JPY 20-F · filed 2021-06-29 | 99.46B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 242.44B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 93.55B JPY 20-F · filed 2019-06-27 |